Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002351546 | SCV002654362 | uncertain significance | Cardiovascular phenotype | 2021-11-16 | criteria provided, single submitter | clinical testing | The c.549+4_549+7delAGTG intronic variant, located in intron 7 of the TNNI3 gene, results from a deletion of 4 nucleotides within intron 7 of the TNNI3 gene. These nucleotide positions are well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |